menu
    • menu

    Company profile for Anavex Life Sciences

    NEW Drugs in Dev.: 3
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Anavex Life Sciences Corp., is a clinical-stage biopharmaceutical company focused on developing treatments for debilitating neurodegenerative and neurodevelopmental diseases. Anavex utilizes precision genetic medicine to treat severe and devastating neurological disorders and is focusing on rare diseases with no available therapy (Rett syndrome) as well as neurodegenerative diseases that are on the rise due to aging population...
    Anavex Life Sciences Corp., is a clinical-stage biopharmaceutical company focused on developing treatments for debilitating neurodegenerative and neurodevelopmental diseases. Anavex utilizes precision genetic medicine to treat severe and devastating neurological disorders and is focusing on rare diseases with no available therapy (Rett syndrome) as well as neurodegenerative diseases that are on the rise due to aging populations (Parkinson's Disease and Alzheimer's Disease)

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Anavex Life SciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    New York City, NY 10019
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.anavex.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/anavex-life-sciences
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Anavex Life Sciences Names Senior VP Global Head Of Neurology
    Anavex Life Sciences Names Senior VP Global Head Of Neurology

    08 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/08/3215276/29248/en/Anavex-Life-Sciences-Appoints-Senior-Vice-President-Global-Head-of-Neurology.html

    GLOBENEWSWIRE
    08 Jan 2026
    Share Share
    Anavex Seeks EMA Re-Examination of Blarcamesine Ruling
    Anavex Seeks EMA Re-Examination of Blarcamesine Ruling

    18 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/18/3207608/29248/en/Anavex-Life-Sciences-Submitted-Request-for-EMA-to-Re-Examine-Its-Opinion.html

    GLOBENEWSWIRE
    18 Dec 2025
    Share Share
    Anavex Provide Update on Regulatory Review in EU for Blarcamesine
    Anavex Provide Update on Regulatory Review in EU for Blarcamesine

    12 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/12/3204857/29248/en/Anavex-Life-Sciences-Provides-Update-on-Regulatory-Review-in-the-EU-for-Blarcamesine-to-Treat-Early-Alzheimer-s-Disease.html

    GLOBENEWSWIRE
    12 Dec 2025
    Share Share
    Anavex Presents Blarcamesine Data at 18th CTAD Conference
    Anavex Presents Blarcamesine Data at 18th CTAD Conference

    26 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/26/3195056/29248/en/Anavex-Life-Sciences-to-Present-Oral-Blarcamesine-Data-at-the-18th-Clinical-Trials-on-Alzheimer-s-Disease-CTAD-Conference.html

    GLOBENEWSWIRE
    26 Nov 2025
    Share Share
    Anavex Life Sciences Reveals Fiscal Q4 2025 Finances & Business
    Anavex Life Sciences Reveals Fiscal Q4 2025 Finances & Business

    25 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/25/3194241/29248/en/Anavex-Life-Sciences-Reports-Fiscal-2025-Fourth-Quarter-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    25 Nov 2025
    Share Share
    Anavex Presents at 44th J.P. Morgan Healthcare Conference
    Anavex Presents at 44th J.P. Morgan Healthcare Conference

    19 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/19/3190832/29248/en/Anavex-Life-Sciences-to-Present-at-the-44TH-ANNUAL-J-P-MORGAN-Healthcare-Conference.html

    GLOBENEWSWIRE
    19 Nov 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search